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EpidemiologyCardiovascular disease (CVD) is the commonest cause of death
in patients with end-stage renal disease (ESRD). Moreover, higher
rates of CVD are seen in patients withmoderate and evenmild renal
dysfunction [1]. Recent studies have indicated [2,3] that even
modest elevations in serum creatinine and urinary albumin
excretion are associated with increased CVD risk, not only in sub-
jects with diabetes or hypertension but also in the general popu-
lation. It is important to screen for renal disease in those with
hypertension, diabetes, and other CVD risk factors because it pre-
dicts those who are at high risk for major CVD events.
Elevated serum creatinine levels are common in the commu-
nity and are strongly associated with older age, treatment for
hypertension, and diabetes in the Framingham Heart Study [4]. In
a Japanese general population, proteinuria, and hyper-
creatininemia or reduced estimated glomerular ﬁltration rate
(eGFR) and their combination were signiﬁcant predictors of CVD
and all-cause mortality [5]. Microalbuminuria confers increased
risk of death and CVD to a similar extent as the metabolic syn-
drome. It is suggested that microalbuminuria should be included
in health examinations as a cardiovascular risk factor besides the
metabolic risk factors [6]. There is a strong association betweenDOI of original article: http://dx.doi.org/10.1016/j.atherosclerosis.2014.08.040.
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albuminuria is associated with an increased risk of ESRD, car-
diovascular events and all-cause mortality [7]. Several studies
have shown that MetS is independently associated with an
increased risk for chronic kidney disease (CKD) and micro-
albuminuria among the general population of western countries
[8,9].
The objective of the paper from Sibilitz et al., published in the
current issue of Atherosclerosis [10], is to examine the relationship
between elevated plasma creatinine but not eGFR and increased
risk of myocardial infarction, ischemic heart disease, and early
death, and to examine these relationships stratiﬁed by some
creatinine categories. The obtained results from a large sample size
of over 10,489 healthy subjects followed up over 30 years with
4499 CVD events are very important. They suggest that moderately
elevated creatinine but not reduced eGFR were associated with
most cardiovascular risk factors, including creatinine level
percentile category, with signiﬁcant trends found with HDL-
cholesterol (inversely), high prevalence of hypertension and dia-
betes and higher BMI. These ﬁndings may be consistent with as-
sociations of the components of MetS rather than cardiovascular
risk factors.
In the future, it will be worthwhile investigating associations
between creatinine or eGFR and myocardial infarction, ischemic
heart disease and early death. Because creatinine levels are strongly
affected by muscle volume which is independent of early renal
dysfunction, different results might be obtained from this study if
authors would measure levels of microalbuminuria.
It is possible that MetS is independently associated with CKD
[8], myocardial infarction and ischemic heart disease [11]. How-
ever, F€arbom P et al. [12] concluded that in patients with hyper-
tension, GFR and microalbuminuria both add independent
prognostic information regarding cardiovascular risk. Importantly,
the cardiovascular risk associated with microalbuminuria in-
creases with the decline in GFR as demonstrated by a signiﬁcant
interaction between microalbuminuria and GFR. Because estima-
tion of total cardiovascular risk is essential for how aggressively
blood pressure and other cardiovascular risk factors should be
treated, simultaneous inclusion of GFR and microalbuminuria in
global cardiovascular risk assessment is likely to have major
clinical utility.r the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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